Human BioSciences, Inc. – Trademark Portfolio
Entity Type: 03
Human BioSciences, Inc. holds 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 23 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 13 trademarks are registered and 3 are pending. Notable registered marks include MEDIFIL, CELLUFIL, COLLATEK, KOLLAVET, and SKINTEMP. The owner is based in Gaithersburg, MD.
940 Clopper Road
Gaithersburg, MD 20878
Showing of trademarks Trademarks
Trademark Classifications
Human BioSciences, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does Human BioSciences, Inc. have?
Human BioSciences, Inc. has 28 U.S. trademarks filed with the USPTO. Of these, 13 registered, 3 pending, 10 abandoned, 2 cancelled.
What trademark classes does Human BioSciences, Inc. file in?
Human BioSciences, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Human BioSciences, Inc.'s most well-known trademarks?
Human BioSciences, Inc.'s registered trademark portfolio includes well-known marks such as MEDIFIL, CELLUFIL, COLLATEK, KOLLAVET, and SKINTEMP. These are among 13 currently registered trademarks in the portfolio.
What is Human BioSciences, Inc.'s trademark registration success rate?
Human BioSciences, Inc. has a 52% trademark registration rate, with 13 out of 25 resolved applications resulting in successful registration. Currently, 3 applications are pending review.